The global Absorbable Pain Relievers for External Use Market growth is projected to reach US$ 10460 million in 2025 to US$ 14260 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.

Global Absorbable Pain Relievers for External Use Market Growth And Outlook 2025-31

The global Absorbable Pain Relievers for External Use market size is predicted to grow from US$ 10460 million in 2025 to US$ 14260 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the ?Absorbable Pain Relievers for External Use Industry Forecast? looks at past sales and reviews total world Absorbable Pain Relievers for External Use sales in 2024, providing a comprehensive analysis by region and market sector of projected Absorbable Pain Relievers for External Use sales for 2025 through 2031. With Absorbable Pain Relievers for External Use sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Absorbable Pain Relievers for External Use industry. This Insight Report provides a comprehensive analysis of the global Absorbable Pain Relievers for External Use landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Absorbable Pain Relievers for External Use portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Absorbable Pain Relievers for External Use market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Absorbable Pain Relievers for External Use and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Absorbable Pain Relievers for External Use. This report presents a comprehensive overview, market shares, and growth opportunities of Absorbable Pain Relievers for External Use market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Gel &nbsp;&nbsp;&nbsp; Spray &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Pharmacy &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; GlaxoSmithKline &nbsp;&nbsp;&nbsp; Reckitt Benckiser Group &nbsp;&nbsp;&nbsp; Teikoku Pharma &nbsp;&nbsp;&nbsp; Topical BioMedics &nbsp;&nbsp;&nbsp; Sun Pharmaceutical Industries &nbsp;&nbsp;&nbsp; AdvaCare Pharma Key Questions Addressed in this Report What is the 10-year outlook for the global Absorbable Pain Relievers for External Use market? What factors are driving Absorbable Pain Relievers for External Use market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Absorbable Pain Relievers for External Use market opportunities vary by end market size? How does Absorbable Pain Relievers for External Use break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Absorbable Pain Relievers for External Use Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Absorbable Pain Relievers for External Use by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Absorbable Pain Relievers for External Use by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Absorbable Pain Relievers for External Use Segment by Type &nbsp;2.2.1 Gel &nbsp;2.2.2 Spray &nbsp;2.2.3 Others &nbsp;2.3 Absorbable Pain Relievers for External Use Sales by Type &nbsp;2.3.1 Global Absorbable Pain Relievers for External Use Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Absorbable Pain Relievers for External Use Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Absorbable Pain Relievers for External Use Sale Price by Type (2020-2025) &nbsp;2.4 Absorbable Pain Relievers for External Use Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Pharmacy &nbsp;2.4.3 Others &nbsp;2.5 Absorbable Pain Relievers for External Use Sales by Application &nbsp;2.5.1 Global Absorbable Pain Relievers for External Use Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Absorbable Pain Relievers for External Use Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Absorbable Pain Relievers for External Use Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Absorbable Pain Relievers for External Use Breakdown Data by Company &nbsp;3.1.1 Global Absorbable Pain Relievers for External Use Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Absorbable Pain Relievers for External Use Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Absorbable Pain Relievers for External Use Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Absorbable Pain Relievers for External Use Revenue by Company (2020-2025) &nbsp;3.2.2 Global Absorbable Pain Relievers for External Use Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Absorbable Pain Relievers for External Use Sale Price by Company &nbsp;3.4 Key Manufacturers Absorbable Pain Relievers for External Use Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Absorbable Pain Relievers for External Use Product Location Distribution &nbsp;3.4.2 Players Absorbable Pain Relievers for External Use Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Absorbable Pain Relievers for External Use by Geographic Region &nbsp;4.1 World Historic Absorbable Pain Relievers for External Use Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Absorbable Pain Relievers for External Use Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Absorbable Pain Relievers for External Use Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Absorbable Pain Relievers for External Use Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Absorbable Pain Relievers for External Use Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Absorbable Pain Relievers for External Use Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Absorbable Pain Relievers for External Use Sales Growth &nbsp;4.4 APAC Absorbable Pain Relievers for External Use Sales Growth &nbsp;4.5 Europe Absorbable Pain Relievers for External Use Sales Growth &nbsp;4.6 Middle East & Africa Absorbable Pain Relievers for External Use Sales Growth 5 Americas &nbsp;5.1 Americas Absorbable Pain Relievers for External Use Sales by Country &nbsp;5.1.1 Americas Absorbable Pain Relievers for External Use Sales by Country (2020-2025) &nbsp;5.1.2 Americas Absorbable Pain Relievers for External Use Revenue by Country (2020-2025) &nbsp;5.2 Americas Absorbable Pain Relievers for External Use Sales by Type (2020-2025) &nbsp;5.3 Americas Absorbable Pain Relievers for External Use Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Absorbable Pain Relievers for External Use Sales by Region &nbsp;6.1.1 APAC Absorbable Pain Relievers for External Use Sales by Region (2020-2025) &nbsp;6.1.2 APAC Absorbable Pain Relievers for External Use Revenue by Region (2020-2025) &nbsp;6.2 APAC Absorbable Pain Relievers for External Use Sales by Type (2020-2025) &nbsp;6.3 APAC Absorbable Pain Relievers for External Use Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Absorbable Pain Relievers for External Use by Country &nbsp;7.1.1 Europe Absorbable Pain Relievers for External Use Sales by Country (2020-2025) &nbsp;7.1.2 Europe Absorbable Pain Relievers for External Use Revenue by Country (2020-2025) &nbsp;7.2 Europe Absorbable Pain Relievers for External Use Sales by Type (2020-2025) &nbsp;7.3 Europe Absorbable Pain Relievers for External Use Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Absorbable Pain Relievers for External Use by Country &nbsp;8.1.1 Middle East & Africa Absorbable Pain Relievers for External Use Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Absorbable Pain Relievers for External Use Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Absorbable Pain Relievers for External Use Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Absorbable Pain Relievers for External Use Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Absorbable Pain Relievers for External Use &nbsp;10.3 Manufacturing Process Analysis of Absorbable Pain Relievers for External Use &nbsp;10.4 Industry Chain Structure of Absorbable Pain Relievers for External Use 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Absorbable Pain Relievers for External Use Distributors &nbsp;11.3 Absorbable Pain Relievers for External Use Customer 12 World Forecast Review for Absorbable Pain Relievers for External Use by Geographic Region &nbsp;12.1 Global Absorbable Pain Relievers for External Use Market Size Forecast by Region &nbsp;12.1.1 Global Absorbable Pain Relievers for External Use Forecast by Region (2026-2031) &nbsp;12.1.2 Global Absorbable Pain Relievers for External Use Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Absorbable Pain Relievers for External Use Forecast by Type (2026-2031) &nbsp;12.7 Global Absorbable Pain Relievers for External Use Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Sanofi &nbsp;13.1.1 Sanofi Company Information &nbsp;13.1.2 Sanofi Absorbable Pain Relievers for External Use Product Portfolios and Specifications &nbsp;13.1.3 Sanofi Absorbable Pain Relievers for External Use Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Sanofi Main Business Overview &nbsp;13.1.5 Sanofi Latest Developments &nbsp;13.2 Johnson & Johnson &nbsp;13.2.1 Johnson & Johnson Company Information &nbsp;13.2.2 Johnson & Johnson Absorbable Pain Relievers for External Use Product Portfolios and Specifications &nbsp;13.2.3 Johnson & Johnson Absorbable Pain Relievers for External Use Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Johnson & Johnson Main Business Overview &nbsp;13.2.5 Johnson & Johnson Latest Developments &nbsp;13.3 Novartis &nbsp;13.3.1 Novartis Company Information &nbsp;13.3.2 Novartis Absorbable Pain Relievers for External Use Product Portfolios and Specifications &nbsp;13.3.3 Novartis Absorbable Pain Relievers for External Use Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Novartis Main Business Overview &nbsp;13.3.5 Novartis Latest Developments &nbsp;13.4 Pfizer &nbsp;13.4.1 Pfizer Company Information &nbsp;13.4.2 Pfizer Absorbable Pain Relievers for External Use Product Portfolios and Specifications &nbsp;13.4.3 Pfizer Absorbable Pain Relievers for External Use Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Pfizer Main Business Overview &nbsp;13.4.5 Pfizer Latest Developments &nbsp;13.5 GlaxoSmithKline &nbsp;13.5.1 GlaxoSmithKline Company Information &nbsp;13.5.2 GlaxoSmithKline Absorbable Pain Relievers for External Use Product Portfolios and Specifications &nbsp;13.5.3 GlaxoSmithKline Absorbable Pain Relievers for External Use Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 GlaxoSmithKline Main Business Overview &nbsp;13.5.5 GlaxoSmithKline Latest Developments &nbsp;13.6 Reckitt Benckiser Group &nbsp;13.6.1 Reckitt Benckiser Group Company Information &nbsp;13.6.2 Reckitt Benckiser Group Absorbable Pain Relievers for External Use Product Portfolios and Specifications &nbsp;13.6.3 Reckitt Benckiser Group Absorbable Pain Relievers for External Use Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Reckitt Benckiser Group Main Business Overview &nbsp;13.6.5 Reckitt Benckiser Group Latest Developments &nbsp;13.7 Teikoku Pharma &nbsp;13.7.1 Teikoku Pharma Company Information &nbsp;13.7.2 Teikoku Pharma Absorbable Pain Relievers for External Use Product Portfolios and Specifications &nbsp;13.7.3 Teikoku Pharma Absorbable Pain Relievers for External Use Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Teikoku Pharma Main Business Overview &nbsp;13.7.5 Teikoku Pharma Latest Developments &nbsp;13.8 Topical BioMedics &nbsp;13.8.1 Topical BioMedics Company Information &nbsp;13.8.2 Topical BioMedics Absorbable Pain Relievers for External Use Product Portfolios and Specifications &nbsp;13.8.3 Topical BioMedics Absorbable Pain Relievers for External Use Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Topical BioMedics Main Business Overview &nbsp;13.8.5 Topical BioMedics Latest Developments &nbsp;13.9 Sun Pharmaceutical Industries &nbsp;13.9.1 Sun Pharmaceutical Industries Company Information &nbsp;13.9.2 Sun Pharmaceutical Industries Absorbable Pain Relievers for External Use Product Portfolios and Specifications &nbsp;13.9.3 Sun Pharmaceutical Industries Absorbable Pain Relievers for External Use Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Sun Pharmaceutical Industries Main Business Overview &nbsp;13.9.5 Sun Pharmaceutical Industries Latest Developments &nbsp;13.10 AdvaCare Pharma &nbsp;13.10.1 AdvaCare Pharma Company Information &nbsp;13.10.2 AdvaCare Pharma Absorbable Pain Relievers for External Use Product Portfolios and Specifications &nbsp;13.10.3 AdvaCare Pharma Absorbable Pain Relievers for External Use Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 AdvaCare Pharma Main Business Overview &nbsp;13.10.5 AdvaCare Pharma Latest Developments 14 Research Findings and Conclusion

Report	Global Absorbable Pain Relievers for External Use Market Growth 2025-2031
Selected License	Multi ID: LPI9076

Buyer Information

Order Summary